Related Experiment Video
Updated: May 5, 2026
07:57
Integrated Compensatory Responses in a Human Model of Hemorrhage
Published on: November 20, 2016
12.4K
Extremely early initiation of vasopressors might not decrease short-term mortality for adults with septic shock: a
Cheng-Hsin Ma1, Jack Healy2,3, Ebrima Kinteh2
1Department of Medical Education, Linkou Chang Gung Memorial Hospital, 5 Fu-Shin Street, Gueishan district, Taoyuan, 333, Taiwan.
Annals of Intensive Care
|January 26, 2025
Summary
Early vasopressor therapy in septic shock may reduce mortality, especially when initiated within one to three hours of diagnosis. However, results vary due to differing definitions, requiring cautious interpretation and further research.
Area of Science:
- Critical Care Medicine
- Pharmacology
- Clinical Trials
Background:
- Optimal timing for vasopressor therapy in septic shock is not well-defined.
- This study evaluates early versus late vasopressor initiation's impact on patient outcomes.
Purpose of the Study:
- To assess the effect of early vs. late vasopressor administration on short-term mortality in septic shock patients.
- To identify optimal timing for vasopressor initiation to improve survival.
Main Methods:
- Systematic review and meta-analysis of PubMed, Embase, and Cochrane databases.
- Included studies compared early and late vasopressor administration in septic shock.
- Primary outcome was short-term mortality; subgroup analyses explored initiation timing.
Main Results:
- Eleven studies (6,661 patients) analyzed; 'early' definition varied (1-7 hours).
- No significant difference in short-term mortality in combined analysis (3,757 patients).
- Lower mortality observed in subgroups with 1-3 hour initiation (OR: 0.70) and when using septic shock diagnosis as time zero (OR: 0.64).
Conclusions:
- Earlier vasopressor initiation (1-3 hours post-septic shock diagnosis) may reduce short-term mortality in specific subgroups.
- Heterogeneity in definitions and confounding factors necessitate cautious interpretation.
- Further standardized research is needed to confirm optimal vasopressor timing for septic shock survival.
